BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 9, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for Feb. 5, 2021

Feb. 5, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Commonwealth Diagnostics International, Real Time Medical Systems, Seqwell, T2 Biosystems, Zimmer Biomet.
Read More
RNA virus illustration
Newco news

Covicept lands Forbion backing for mission to tackle RNA viruses

Feb. 5, 2021
By Michael Fitzhugh
Covicept Therapeutics Inc., a young San Diego-based company focused on developing a small molecule to inhibit the replication and spread of SARS-CoV-2 and other RNA viruses, has launched with $2.3 million in seed funding from European VC firm Forbion. The company, spun out of research at the University of California, San Diego, aims to initiate its first clinical study in the middle of 2021.
Read More

Regulatory actions for Feb. 5, 2021

Feb. 5, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Actinogen, BMS, Celltrion, Innocare, J&J, Novavax, RDIF, TG.
Read More

Other news to note for Feb. 5, 2021

Feb. 5, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alphageneron, Curevac, Diamond, Hyloris, Multimmune, Onxeo, Pfizer, Purna .
Read More

In the clinic for Feb. 5, 2021

Feb. 5, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achilles, Astrazeneca, Covaxx, GSK, I-Mab, PTC, Sanofi, Spark, Spero.
Read More
FDA icons

Regulatory attorney says warning letters likely to spike under new FDA administration

Feb. 4, 2021
By Mark McCarty
U.S. FDA warning letters have been a staple of regulatory life since the late 1990s, but James Boiani, a regulatory attorney with Epstein, Becker & Green P.C., said it’s no stretch of the imagination that warning letter volumes will jump in 2021. This is to some extent because the volume of warning letters dropped significantly over the past four years, and Boiani advised that all FDA-regulated industries will see more warning letters unless they are communicative with the agency about inspectional findings.
Read More

Regulatory front for Feb. 4, 2021

Feb. 4, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: CEO tells patients their deaths were impending for profit; DeGette, Bucshon ink new testing legislation; NICE: Acupath’s URO17 test needs more data.
Read More

Regulatory actions for Feb. 4, 2021

Feb. 4, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: B-Secur, Claronav Kolahi, RapidAI, Precision Biomonitoring, Precision Spine.
Read More

Other news to note for Feb. 4, 2021

Feb. 4, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 23andme, Ambu, Coopercompanies, Curadel Surgical Innovations, Bioaffinity Technologies, Dxs, Emitbio, Essilorluxottica, Horizon Therapeutics, Illumina, Insightec, Medidata, Mnx Global Logistics, Mprobe, Neogenomics, Newronika, Oxford Immunotec, Parexel, Philips, Phillips-Medisize, Pieriandx, Quidel, RNA Disease Diagnostics, Sera Prognostics, Shanghai Fosun Long March Medical Science, Sightglass Vision, Stella Diagnostics, Subcuject, Tcg Lifesciences, Varian, Vuzix, Webops.
Read More

BioWorld MedTech’s Diagnostics Extra for Feb. 4, 2021

Feb. 4, 2021
By Meg Bryant
Keeping you up to date on recent developments in diagnostics, including: A deep learning tool to predict cardiovascular risk; Smartphone-based COVID-19 test; PCOS passed on in the epigenes.
Read More
Previous 1 2 … 287 288 289 290 291 292 293 294 295 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 8, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • CAR T cell attacking cancer cells

    Development and characterization of anti-CD19 in vivo CAR T therapy

    BioWorld Science
    Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
  • Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

    BioWorld Science
    The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing